tiprankstipranks
Trending News
More News >
Anika Therapeutics sees FY25 adjusted EBITDA down 3% to up 3%
PremiumThe FlyAnika Therapeutics sees FY25 adjusted EBITDA down 3% to up 3%
1M ago
Is ANIK a Buy, Before Earnings?
Premium
Pre-Earnings
Is ANIK a Buy, Before Earnings?
1M ago
Microsoft, PayPal downgraded: Wall Street’s top analyst calls
Premium
The Fly
Microsoft, PayPal downgraded: Wall Street’s top analyst calls
2M ago
Anika Therapeutics price target lowered to $20 from $25 at Barrington
PremiumThe FlyAnika Therapeutics price target lowered to $20 from $25 at Barrington
3M ago
Anika Therapeutics Reports Steady Growth and Strategic Focus
Premium
Company Announcements
Anika Therapeutics Reports Steady Growth and Strategic Focus
3M ago
Anika Therapeutics reports Q4 EPS (3c), consensus 9c
Premium
The Fly
Anika Therapeutics reports Q4 EPS (3c), consensus 9c
3M ago
Anika Therapeutics Focuses on Core Growth Amid Restructuring
PremiumCompany AnnouncementsAnika Therapeutics Focuses on Core Growth Amid Restructuring
7M ago
Anika Therapeutics Refocuses on Core Technology and Growth
Premium
Company Announcements
Anika Therapeutics Refocuses on Core Technology and Growth
8M ago
Anika Therapeutics announces Arthrosurface sale, plan to divest Parcus Medical
Premium
The Fly
Anika Therapeutics announces Arthrosurface sale, plan to divest Parcus Medical
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100